Your Article Summary
Kumar S et al. - Here authors summarize the currently available data and present perspective on the problem and potential options to overcome this problem. Specifically, they recommend early mobilization of stem cells, preferable with in the first 4 cycles of initial therapy, in patients treated with novel agents and encourage participation in clinical trials evaluating novel approaches to stem cell mobilization.
Related Articles
History of cord blood transplantation
Bone Marrow Transplantation, 10/07/09
Relevance Score: 81%
Factors affecting neutrophil recovery after autologous bone marrow-derived stem cell transplantation in patients with acute myeloid leukemia
Transplantation Proceedings, 11/23/09
Relevance Score: 80%
Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma
American Journal of Hematology, 11/10/09
Relevance Score: 80%
Scrub typhus induced by peripheral blood stem cell transplantation in the immunocompromised patient: diagnostic usefulness of nested polymerase chain reaction
Transfusion, 10/26/09
Relevance Score: 80%
Natural course of HCV infection in childhood cancer survivors
Supportive Care in Cancer, 10/30/09
Relevance Score: 77%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes
Bone Marrow Transplantation, 12/03/09
Dermatologic manifestations of hematopoietic stem cell transplantation: understanding and management
Expert Review of Dermatology, 12/03/09
Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut points to determine low, intermediate and high risk groups: The flexible HCT-CI is the best predictor of NRM and OS in a population of patients undergoing allo-RIC
Biology of Blood and Marrow Transplantation, 12/03/09
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Pulmonary Alveolar Proteinosis as a Terminal Complication in a Case of Myelodysplastic Syndrome with idic(20q-)
Acta Haematologica, 12/04/09
Environmental-mediated drug resistance: a target for multiple myeloma therapy
Expert Review of Hematology, 12/02/09

See Latest Articles